APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anlotinib Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Anlotinib Drugs Market Analysis and Forecast 2026-2032

Report ID 17396436022 January 2026193 pages

Choose your research edition.

Industry ResearchAnlotinib Drugs Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Anlotinib Drugs Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Anlotinib Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anlotinib Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Anlotinib Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Anlotinib Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Anlotinib Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anlotinib Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anlotinib Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anlotinib Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Anlotinib Drugs include CHIA TAI TIANQING. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Anlotinib Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anlotinib Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Anlotinib Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anlotinib Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anlotinib Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Anlotinib Drugs sales, projected growth trends, production technology, application and end-user industry.

Anlotinib Drugs Segment by Company

CHIA TAI TIANQING

Anlotinib Drugs Segment by Type

8mg Capsules

12mg Capsules

10mg Capsules

Anlotinib Drugs Segment by Application

Hospital

Drugs Store

Anlotinib Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anlotinib Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anlotinib Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anlotinib Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Anlotinib Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Anlotinib Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anlotinib Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anlotinib Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 8mg Capsules Major Manufacturers Table 3. 12mg Capsules Major Manufacturers Table 4. 10mg Capsules Major Manufacturers Table 5. Global Anlotinib Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Drugs Store Major Manufacturers Table 8. Anlotinib Drugs Industry Trends Table 9. Anlotinib Drugs Industry Drivers Table 10. Anlotinib Drugs Industry Opportunities and Challenges Table 11. Anlotinib Drugs Industry Restraints Table 12. Global Anlotinib Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Anlotinib Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Anlotinib Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Anlotinib Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Anlotinib Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Anlotinib Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Anlotinib Drugs Sales by Region (2021-2026) & (K Units) Table 19. Global Anlotinib Drugs Sales by Region (2027-2032) & (K Units) Table 20. Global Anlotinib Drugs Sales Market Share by Region (2021-2026) Table 21. Global Anlotinib Drugs Sales Market Share by Region (2027-2032) Table 22. Global Anlotinib Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Anlotinib Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Anlotinib Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Anlotinib Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Anlotinib Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Anlotinib Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Anlotinib Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Anlotinib Drugs Manufacturers, Product Type & Application Table 30. Global Anlotinib Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Anlotinib Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Anlotinib Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Anlotinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Anlotinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Anlotinib Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Anlotinib Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Anlotinib Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Anlotinib Drugs Sales by Type (2021-2026) & (K Units) Table 40. Global Anlotinib Drugs Sales by Type (2027-2032) & (K Units) Table 41. Global Anlotinib Drugs Sales Market Share by Type (2021-2026) Table 42. Global Anlotinib Drugs Sales Market Share by Type (2027-2032) Table 43. Global Anlotinib Drugs Price by Type (2021-2026) & (US$/Unit) Table 44. Global Anlotinib Drugs Price by Type (2027-2032) & (US$/Unit) Table 45. Global Anlotinib Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Anlotinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Anlotinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Anlotinib Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Anlotinib Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Anlotinib Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Anlotinib Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Anlotinib Drugs Sales by Application (2027-2032) & (K Units) Table 53. Global Anlotinib Drugs Sales Market Share by Application (2021-2026) Table 54. Global Anlotinib Drugs Sales Market Share by Application (2027-2032) Table 55. Global Anlotinib Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Anlotinib Drugs Price by Application (2027-2032) & (US$/Unit) Table 57. CHIA TAI TIANQING Company Information Table 58. CHIA TAI TIANQING Business Overview Table 59. CHIA TAI TIANQING Anlotinib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. CHIA TAI TIANQING Anlotinib Drugs Product Portfolio Table 61. CHIA TAI TIANQING Recent Development Table 62. North America Anlotinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 63. North America Anlotinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 64. North America Anlotinib Drugs Sales by Type (2021-2026) & (K Units) Table 65. North America Anlotinib Drugs Sales by Type (2027-2032) & (K Units) Table 66. North America Anlotinib Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 67. North America Anlotinib Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 68. North America Anlotinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 69. North America Anlotinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 70. North America Anlotinib Drugs Sales by Application (2021-2026) & (K Units) Table 71. North America Anlotinib Drugs Sales by Application (2027-2032) & (K Units) Table 72. North America Anlotinib Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 73. North America Anlotinib Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 74. North America Anlotinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Anlotinib Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 76. North America Anlotinib Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 77. North America Anlotinib Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 78. North America Anlotinib Drugs Sales by Country (2021-2026) & (K Units) Table 79. North America Anlotinib Drugs Sales by Country (2027-2032) & (K Units) Table 80. North America Anlotinib Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 81. North America Anlotinib Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 82. United States Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 83. Canada Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 84. Europe Anlotinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 85. Europe Anlotinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 86. Europe Anlotinib Drugs Sales by Type (2021-2026) & (K Units) Table 87. Europe Anlotinib Drugs Sales by Type (2027-2032) & (K Units) Table 88. Europe Anlotinib Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 89. Europe Anlotinib Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 90. Europe Anlotinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 91. Europe Anlotinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 92. Europe Anlotinib Drugs Sales by Application (2021-2026) & (K Units) Table 93. Europe Anlotinib Drugs Sales by Application (2027-2032) & (K Units) Table 94. Europe Anlotinib Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 95. Europe Anlotinib Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 96. Europe Anlotinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Anlotinib Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 98. Europe Anlotinib Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 99. Europe Anlotinib Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 100. Europe Anlotinib Drugs Sales by Country (2021-2026) & (K Units) Table 101. Europe Anlotinib Drugs Sales by Country (2027-2032) & (K Units) Table 102. Europe Anlotinib Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 103. Europe Anlotinib Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 104. Germany Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 105. France Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 106. U.K. Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 107. Italy Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 108. Netherlands Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 109. China Anlotinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 110. China Anlotinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 111. China Anlotinib Drugs Sales by Type (2021-2026) & (K Units) Table 112. China Anlotinib Drugs Sales by Type (2027-2032) & (K Units) Table 113. China Anlotinib Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 114. China Anlotinib Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 115. China Anlotinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 116. China Anlotinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 117. China Anlotinib Drugs Sales by Application (2021-2026) & (K Units) Table 118. China Anlotinib Drugs Sales by Application (2027-2032) & (K Units) Table 119. China Anlotinib Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 120. China Anlotinib Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 121. Asia Anlotinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 122. Asia Anlotinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 123. Asia Anlotinib Drugs Sales by Type (2021-2026) & (K Units) Table 124. Asia Anlotinib Drugs Sales by Type (2027-2032) & (K Units) Table 125. Asia Anlotinib Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 126. Asia Anlotinib Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 127. Asia Anlotinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 128. Asia Anlotinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Anlotinib Drugs Sales by Application (2021-2026) & (K Units) Table 130. Asia Anlotinib Drugs Sales by Application (2027-2032) & (K Units) Table 131. Asia Anlotinib Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 132. Asia Anlotinib Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 133. Asia Anlotinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Anlotinib Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Asia Anlotinib Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Asia Anlotinib Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 137. Asia Anlotinib Drugs Sales by Country (2021-2026) & (K Units) Table 138. Asia Anlotinib Drugs Sales by Country (2027-2032) & (K Units) Table 139. Asia Anlotinib Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 140. Asia Anlotinib Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 141. Japan Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 142. South Korea Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 143. India Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 144. Australia Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 145. China Taiwan Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 146. Southeast Asia Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 147. SAMEA Anlotinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 148. SAMEA Anlotinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 149. SAMEA Anlotinib Drugs Sales by Type (2021-2026) & (K Units) Table 150. SAMEA Anlotinib Drugs Sales by Type (2027-2032) & (K Units) Table 151. SAMEA Anlotinib Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 152. SAMEA Anlotinib Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 153. SAMEA Anlotinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 154. SAMEA Anlotinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 155. SAMEA Anlotinib Drugs Sales by Application (2021-2026) & (K Units) Table 156. SAMEA Anlotinib Drugs Sales by Application (2027-2032) & (K Units) Table 157. SAMEA Anlotinib Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 158. SAMEA Anlotinib Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 159. SAMEA Anlotinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. SAMEA Anlotinib Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. SAMEA Anlotinib Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. SAMEA Anlotinib Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 163. SAMEA Anlotinib Drugs Sales by Country (2021-2026) & (K Units) Table 164. SAMEA Anlotinib Drugs Sales by Country (2027-2032) & (K Units) Table 165. SAMEA Anlotinib Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 166. SAMEA Anlotinib Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 167. Brazil Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 168. Argentina Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 169. Chile Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 170. Colombia Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 171. Peru Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 172. Saudi Arabia Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 173. Israel Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 174. UAE Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 175. Turkey Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 176. Iran Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 177. Egypt Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Anlotinib Drugs Distributors List Table 181. Anlotinib Drugs Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Anlotinib Drugs Image Figure 2. Global Anlotinib Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anlotinib Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. 8mg Capsules Image Figure 5. 12mg Capsules Image Figure 6. 10mg Capsules Image Figure 7. Global Anlotinib Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Anlotinib Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Drugs Store Image Figure 11. Global Anlotinib Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Anlotinib Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Anlotinib Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Anlotinib Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Anlotinib Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Anlotinib Drugs Sales (2021-2032) & (K Units) Figure 17. Global Anlotinib Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Anlotinib Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Anlotinib Drugs Sales YoY (2021-2032) & (K Units) Figure 20. Europe Anlotinib Drugs Sales YoY (2021-2032) & (K Units) Figure 21. China Anlotinib Drugs Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Anlotinib Drugs Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Anlotinib Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Global Anlotinib Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Anlotinib Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Anlotinib Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Anlotinib Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Anlotinib Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Anlotinib Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Anlotinib Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Anlotinib Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Anlotinib Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Anlotinib Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Anlotinib Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Anlotinib Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Anlotinib Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Anlotinib Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Anlotinib Drugs Revenue Share by Type (2021-2032) Figure 40. North America Anlotinib Drugs Sales Share by Type (2021-2032) Figure 41. North America Anlotinib Drugs Revenue Share by Application (2021-2032) Figure 42. North America Anlotinib Drugs Sales Share by Application (2021-2032) Figure 43. North America Anlotinib Drugs Revenue Share by Country (2021-2032) Figure 44. North America Anlotinib Drugs Sales Share by Country (2021-2032) Figure 45. Europe Anlotinib Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Anlotinib Drugs Sales Share by Type (2021-2032) Figure 47. Europe Anlotinib Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Anlotinib Drugs Sales Share by Application (2021-2032) Figure 49. Europe Anlotinib Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Anlotinib Drugs Sales Share by Country (2021-2032) Figure 51. China Anlotinib Drugs Revenue Share by Type (2021-2032) Figure 52. China Anlotinib Drugs Sales Share by Type (2021-2032) Figure 53. China Anlotinib Drugs Revenue Share by Application (2021-2032) Figure 54. China Anlotinib Drugs Sales Share by Application (2021-2032) Figure 55. Asia Anlotinib Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Anlotinib Drugs Sales Share by Type (2021-2032) Figure 57. Asia Anlotinib Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Anlotinib Drugs Sales Share by Application (2021-2032) Figure 59. Asia Anlotinib Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Anlotinib Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Anlotinib Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Anlotinib Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Anlotinib Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Anlotinib Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Anlotinib Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Anlotinib Drugs Sales Share by Country (2021-2032) Figure 67. Anlotinib Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Anlotinib Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 8mg Capsules
  • 12mg Capsules
  • 10mg Capsules
Applications
  • Hospital
  • Drugs Store
Companies covered
  • CHIA TAI TIANQING

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anlotinib Drugs Market by Type
  3. 1.2.1 Global Anlotinib Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 8mg Capsules
  5. 1.2.3 12mg Capsules
  6. 1.2.4 10mg Capsules
  7. 1.3 Anlotinib Drugs Market by Application
  8. 1.3.1 Global Anlotinib Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Drugs Store
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Anlotinib Drugs Market Dynamics
  1. 2.1 Anlotinib Drugs Industry Trends
  2. 2.2 Anlotinib Drugs Industry Drivers
  3. 2.3 Anlotinib Drugs Industry Opportunities and Challenges
  4. 2.4 Anlotinib Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Anlotinib Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Anlotinib Drugs Revenue by Region
  3. 3.2.1 Global Anlotinib Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anlotinib Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Anlotinib Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Anlotinib Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Anlotinib Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Anlotinib Drugs Sales by Region
  9. 3.4.1 Global Anlotinib Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Anlotinib Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Anlotinib Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Anlotinib Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Anlotinib Drugs Revenue by Manufacturers
  2. 4.1.1 Global Anlotinib Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Anlotinib Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Anlotinib Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anlotinib Drugs Sales by Manufacturers
  6. 4.2.1 Global Anlotinib Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Anlotinib Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Anlotinib Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Anlotinib Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Anlotinib Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Anlotinib Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Anlotinib Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Anlotinib Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Anlotinib Drugs Market CR5 and HHI
  16. 4.8.2 2025 Anlotinib Drugs Tier 1, Tier 2, and Tier 3
5 Anlotinib Drugs Market by Type
  1. 5.1 Global Anlotinib Drugs Revenue by Type
  2. 5.1.1 Global Anlotinib Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Anlotinib Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Anlotinib Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Anlotinib Drugs Sales by Type
  6. 5.2.1 Global Anlotinib Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anlotinib Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Anlotinib Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Anlotinib Drugs Price by Type
6 Anlotinib Drugs Market by Application
  1. 6.1 Global Anlotinib Drugs Revenue by Application
  2. 6.1.1 Global Anlotinib Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Anlotinib Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Anlotinib Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Anlotinib Drugs Sales by Application
  6. 6.2.1 Global Anlotinib Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Anlotinib Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Anlotinib Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Anlotinib Drugs Price by Application
7 Company Profiles
  1. 7.1 CHIA TAI TIANQING
  2. 7.1.1 CHIA TAI TIANQING Company Information
  3. 7.1.2 CHIA TAI TIANQING Business Overview
  4. 7.1.3 CHIA TAI TIANQING Anlotinib Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CHIA TAI TIANQING Anlotinib Drugs Product Portfolio
  6. 7.1.5 CHIA TAI TIANQING Recent Developments
8 North America
  1. 8.1 North America Anlotinib Drugs Market Size by Type
  2. 8.1.1 North America Anlotinib Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Anlotinib Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Anlotinib Drugs Price by Type (2021-2032)
  5. 8.2 North America Anlotinib Drugs Market Size by Application
  6. 8.2.1 North America Anlotinib Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Anlotinib Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Anlotinib Drugs Price by Application (2021-2032)
  9. 8.3 North America Anlotinib Drugs Market Size by Country
  10. 8.3.1 North America Anlotinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Anlotinib Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Anlotinib Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Anlotinib Drugs Market Size by Type
  2. 9.1.1 Europe Anlotinib Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Anlotinib Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Anlotinib Drugs Price by Type (2021-2032)
  5. 9.2 Europe Anlotinib Drugs Market Size by Application
  6. 9.2.1 Europe Anlotinib Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Anlotinib Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Anlotinib Drugs Price by Application (2021-2032)
  9. 9.3 Europe Anlotinib Drugs Market Size by Country
  10. 9.3.1 Europe Anlotinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Anlotinib Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Anlotinib Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Anlotinib Drugs Market Size by Type
  2. 10.1.1 China Anlotinib Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Anlotinib Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Anlotinib Drugs Price by Type (2021-2032)
  5. 10.2 China Anlotinib Drugs Market Size by Application
  6. 10.2.1 China Anlotinib Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Anlotinib Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Anlotinib Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anlotinib Drugs Market Size by Type
  2. 11.1.1 Asia Anlotinib Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Anlotinib Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Anlotinib Drugs Price by Type (2021-2032)
  5. 11.2 Asia Anlotinib Drugs Market Size by Application
  6. 11.2.1 Asia Anlotinib Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Anlotinib Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Anlotinib Drugs Price by Application (2021-2032)
  9. 11.3 Asia Anlotinib Drugs Market Size by Country
  10. 11.3.1 Asia Anlotinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Anlotinib Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Anlotinib Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anlotinib Drugs Market Size by Type
  2. 12.1.1 SAMEA Anlotinib Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Anlotinib Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Anlotinib Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Anlotinib Drugs Market Size by Application
  6. 12.2.1 SAMEA Anlotinib Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Anlotinib Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Anlotinib Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Anlotinib Drugs Market Size by Country
  10. 12.3.1 SAMEA Anlotinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Anlotinib Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Anlotinib Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Anlotinib Drugs Value Chain Analysis
  2. 13.1.1 Anlotinib Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Anlotinib Drugs Production Mode & Process
  6. 13.2 Anlotinib Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Anlotinib Drugs Distributors
  9. 13.2.3 Anlotinib Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst